Nosocomial Infection Clinical Trial
— BCAOfficial title:
The Effect of Fluorescent Marking and BCA Methods of Patient Unit Cleaning in Intensive Care
Verified date | April 2020 |
Source | Cumhuriyet University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Effective cleaning of surfaces in the hospital environment is an absolute necessity to reduce
pathogen transmission. Multi Drug Resistant Organisms (MDRO) in ICU are among the leading
causes of hospital-acquired infections. Today, the growing prevalence of MDRO has made it
more important than ever to clean contaminated surfaces with appropriate aseptic cleaning
procedures, to protect patients and personnel. Despite the disinfection and sterilization
methods, microorganisms that reach a sufficient concentration in the hospital environment
survive for long periods and can cause serious transmission via contaminated hands of
healthcare workers. In this context, surface cleaning and disinfection procedures in the
hospital environment reduce cross-contamination of the health care units and disease-causing
pathogens. Recently, environmental cleaning and disinfection have become important as well as
the evaluation of cleanliness.
The aim of this study is to evaluate the effectiveness and usability of BCA method, which is
a new approach in evaluating the effectiveness of environmental cleanliness in intensive care
units. fluoroscan gel marking, microbiological sampling and BCA assay methods will be
compared to evaluate the effectiveness and usability of the BCA method. (PRO1 Micro Hygiene
Monitoring System that System consisting of protein pen and device that analyzes with BCA
method).
Status | Completed |
Enrollment | 40 |
Est. completion date | April 21, 2020 |
Est. primary completion date | March 16, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: A patient infected with resistant microorganism in the unit is in the same unit for at least 72 hours The first BCA measurement when the unit is discharged gives a result indicating the unit is dirty.- Exclusion Criteria: - The patient who has been infected with the resistant microorganism in the unit has been hospitalized for less than 72 hours - The first BCA measurement when the unit is empty does not give a result indicating that the unit is dirty. - Impaired blindness for any reason included in the study - In case the patient is included in the study but new patient admission to the unit before the cleaning stages are completed - In the event that other employees who are included in the work but do not complete the cleaning stages enter and leave the unit, the work will be terminated. |
Country | Name | City | State |
---|---|---|---|
Turkey | Cumhuriyet University | Sivas |
Lead Sponsor | Collaborator |
---|---|
Cumhuriyet University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To evaluate the effectiveness of cleaning | The absence of gel residue on the surfaces indicates that the wiping process is effective. Microbiological samples will determine the presence and amount of bacteria (colony) in the environment. It is aimed that bacteria cannot be produced in the samples taken from the environment after cleaning. The BCA protein samples will be analyzed by the researcher using the PRO 1 Micro hygiene monitoring device. PRO 1 Micro hygiene monitoring device will detect the presence of biological material on the surfaces. The presence and amount of bacteria on the surface will be determined with BCA protein. The presence and amount of bacteria can be detected by BCA protein swab, but not by bacterial species. The device is capable of detecting the biological load between 1 - 10 micrograms. Areas with values above 5 micrograms will be considered as dirty, areas with values below 5 micrograms will be considered as clean | 1 year | |
Secondary | To evaluate the effectiveness of BCA method | If cleaning is not considered to be effective, cleaning will be repeated. If the results of samples taken with BCA protein pen after effective cleaning are below 5 microns, it is concluded that the area, is clean. If the BCA method (micrograms) shows clean or similar results in microbiological samples (colony), it will be concluded that the BCA method can be used to evaluate surface cleanliness. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03365635 -
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
|
Phase 4 | |
Recruiting |
NCT05904535 -
Novel Diagnostic Methods to Identify External Ventricular Drain Associated Infections
|
||
Completed |
NCT01704430 -
Glutamine to Improve Outcomes in Cardiac Surgery
|
N/A | |
Terminated |
NCT01225159 -
Tight Glycaemic Control During Cardiac Surgery
|
N/A | |
Recruiting |
NCT04659356 -
NOSOcomial COVID-19 in ICU (NOSOCOVID)
|
||
Terminated |
NCT03423147 -
Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor
|
Phase 2 | |
Completed |
NCT03429283 -
Achromobacter Xylosoxidans (ACHX) Infections
|
||
Recruiting |
NCT04252651 -
Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
|
||
Completed |
NCT04405934 -
COG-UK Project Hospital-Onset COVID-19 Infections Study
|
N/A | |
Active, not recruiting |
NCT03865706 -
Inulin for Infections in the Intensive Care Unit
|
Phase 2 | |
Recruiting |
NCT05411562 -
COVID-19 Genomic Sequencing for Nosocomial Outbreak Investigations
|
||
Completed |
NCT03250104 -
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
|
||
Completed |
NCT01763008 -
A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
|
Phase 4 | |
Completed |
NCT00864929 -
An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice
|
N/A | |
Terminated |
NCT01515020 -
Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia
|
Phase 3 | |
Active, not recruiting |
NCT05511129 -
Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU
|
||
Active, not recruiting |
NCT05988853 -
Biosafety of Musical Instruments in the ICU
|
||
Recruiting |
NCT01943331 -
Epidemiological Investigation of CRBSI, VAP, CAUTI in Chinese ICU
|
N/A | |
Completed |
NCT00105625 -
VA Nutrition Study on Immune Function
|
N/A | |
Not yet recruiting |
NCT03857295 -
Infections Following NeuroSurgery (INS)
|